Logo Centene Corporation

Centene Corporation (CNC) stock: analyst price target and their real reliability

Live quote · data updated Oct 14, 2026
Centene Corporation · Health Care · ref. ETF XLV · 62 calls · price $68.86
🏆JPI 2026 portfoliosSee tracking →
What the company does: Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.

📈 Centene Corporation (CNC) stock price

$68.86+89.0% over range
Oct 14, 25low $31.8 · high $69.41Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
47% recommend buying · 17 analysts
📊 JPI status : Centene Corporation is no longer in our current JPI rankings, but appeared in the past (2017) — its upside may be behind it. See the stocks picked in 2017 →

🎯 CNC price target & analyst consensus — price $68.86

The price target · all analysts combined (17 targets)
Highest target · 3 firms of 17$80+16.2%
Median target · of 17 targets$69+0.2%
Lowest target · 1 firm of 17$39-43.4%
Current price$68.86
Where these 17 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price 953% $69 ↔ $80
Below 847% $39 ↔ $67
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Bernstein — 69% of its targets hit on this sector (70 calls tested). It aims for $79 (+15 %), call made on August 4, 2026, maturing on August 4, 2027 (71 d ago).

The 5 reliable analysts $79+15 %
The 12 other firms $67-2.7 %
How to read it: the 5 reliable firms are not filtered by optimism — 3 aim above the price, 2 below, hence their $79 median. “The 12 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy847%
Hold953%
Sell00%
Strong Sell00%
Go deeper on the analysts
All analysts (the consensus)  ·  vs  ·  the best (those who've been right)
💬 A question about Centene Corporation? The JPI assistant answers using our backtest data.

📈 Centene Corporation fundamentals: valuation, margins & growth › open the full page

P/E —Net margin -2.8 %Revenue growth +4.6 %Not (yet) profitable

Revenue, net income and margin per year

Revenue Net income · hover a bar for details
2022
marg. 1 %
2023
Rev +7%Profit +125%
2024
Rev +6%Profit +22%
2025
Rev +19%Profit −302%

🔎 Detailed analyses

🏛️ Which US Congress members hold Centene Corporation (CNC)?

6 Congress members have disclosed CNC buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Susie Lee 5× · 43%Kathy Manning 4× · 43%Gilbert Cisneros 2× · 48%Earl Blumenauer 2× · 38%Daniel Goldman 2× · 25%David McKinley 1× · 38%
→ Full members ranking (who beats the market)

✅ Historical analyst reliability on CNC

Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.

Firm ↕ % right i ↕ Gain vs sector i ↕ Calls i ↕
Monness, Crespi, Hardt 100% +38.4% 3
SVB Leerink 100% +22.2% 3
BMO Capital ↗ 100% +17.4% 6
Stephens & Co. ↗ 100% +11.5% 4
FBR Capital 75% +60.2% 4
Bernstein ↗ 67% +53.7% 3
Credit Suisse 67% +29.0% 12
Cowen & Co. 67% +3.2% 3
B of A Securities ↗ 67% -4.3% 9
Morgan Stanley ↗ 65% +12.5% 26
See the other 15 firms
TD Cowen ↗ 0% -62.3% 2
Wells Fargo ↗ 25% -18.7% 16
Citigroup ↗ 27% -23.2% 11
UBS ↗ 33% +10.2% 3
Cantor Fitzgerald ↗ 37% -3.6% 19
Leerink Swann 40% +28.9% 5
Barclays ↗ 43% -4.9% 21
Goldman Sachs ↗ 50% +2.2% 2
SunTrust Robinson Humphrey 50% +3.3% 2
Susquehanna ↗ 50% +35.0% 2
Oppenheimer ↗ 53% +19.8% 19
Deutsche Bank ↗ 56% +14.7% 9
Truist Securities ↗ 60% +26.3% 10
JP Morgan ↗ 60% +27.7% 5
Jefferies ↗ 64% +8.8% 14

📊 What $1,000 invested in Centene Corporation would be worth › open the full page

In short — $1,000 invested in Centene Corporation 10 years ago would be worth $1,951 today, i.e. +7%/yr on average. Best year: 2017 (+79%), worst: 2025 (-32%). Price performance, excluding dividends.

If I'd invested $1,000 in Centene Corporation

InvestmentWorth todayGain
1 years ago$1,060+6%
3 years ago$783-22%
5 years ago$1,069+7%
→ See Centene Corporation's full return history + gain calculator

Return by year (Centene Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)+56%$1,560 (+56%)
2025-32%$1,060 (+6%)
2024-18%$865 (-14%)
→ See Centene Corporation's full return history + gain calculator
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

📰 Recent news on Centene Corporation

Loading news…

📋 All analyst calls on CNC

Argus Research ↗
Aug 11, 26
▲ Buy · 🎯$80
Price at call : $64.88 — upside +23%
Today : $68.86 — upside +16%
🎯 on CNC : no call matured yet · 📊 on Health : 55.3% · +2.1% (159 calls)
in progress (365j)
matures : Aug 11, 27
JP Morgan ↗
Aug 4, 26
■ Neutral neutral · not a buy · 🎯$67
Price at call : $66.99 — gap to target +0%
Today : $68.86 — gap to target -3%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Aug 4, 27
Bernstein ↗
Aug 3, 26
▲ Outperform · 🎯$79
Price at call : $64.07 — upside +23%
Today : $68.86 — upside +15%
🎯 on CNC : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Aug 3, 27
Barclays ↗
Jul 29, 26
▲ Overweight · 🎯$80
Price at call : $61.82 — upside +29%
Today : $68.86 — upside +16%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jul 29, 27
Baird ↗
Jul 29, 26
■ Neutral neutral · not a buy · 🎯$66
Price at call : $61.82 — gap to target +7%
Today : $68.86 — gap to target -4%
🎯 on CNC : no call matured yet · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Jul 29, 27
TD Cowen ↗
Jul 14, 26
■ Hold neutral · not a buy · 🎯$65
Price at call : $66.61 — gap to target -2%
Today : $68.86 — gap to target -6%
🎯 on CNC : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 14, 27
▲ Buy · 🎯$78
Price at call : $68.72 — upside +14%
Today : $68.86 — upside +13%
🎯 on CNC : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jul 14, 27
Wells Fargo ↗
Jul 13, 26
■ Equal-Weight neutral · not a buy · 🎯$69
Price at call : $68.72 — gap to target +0%
Today : $68.86 — gap to target +0%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 13, 27
See the other 54 calls, newest to oldest
RBC Capital ↗
Jul 9, 26
■ Sector Perform neutral · not a buy · 🎯$71
Price at call : $67.35 — gap to target +5%
Today : $68.86 — gap to target +3%
🎯 on CNC : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 9, 27
▲ Overweight · 🎯$75
Price at call : $66.12 — upside +13%
Today : $68.86 — upside +9%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Jul 7, 27
RBC Capital ↗
Jun 23, 26
■ Sector Perform neutral · not a buy · 🎯$70
Price at call : $62.97 — gap to target +11%
Today : $68.86 — gap to target +2%
🎯 on CNC : no call matured yet · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jun 23, 27
Mizuho ↗
Jun 8, 26
■ Neutral neutral · not a buy · 🎯$63
Price at call : $66.21 — gap to target -5%
Today : $68.86 — gap to target -9%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Jun 8, 27
JP Morgan ↗
Jun 8, 26
■ Neutral neutral · not a buy · 🎯$60
Price at call : $66.21 — gap to target -9%
Today : $68.86 — gap to target -13%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Jun 8, 27
▲ Buy · 🎯$74
Price at call : $62.33 — upside +19%
Today : $68.86 — upside +7%
🎯 on CNC : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Jun 4, 27
■ Equal-Weight neutral · not a buy · 🎯$57
Price at call : $62.33 — gap to target -9%
Today : $68.86 — gap to target -17%
🎯 on CNC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Jun 4, 27
▲ Buy · 🎯$71
Price at call : $59.99 — upside +18%
Today : $68.86 — upside +3%
🎯 on CNC : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Jun 1, 27
Barclays ↗
May 26, 26
▲ Overweight · 🎯$75
Price at call : $58.82 — upside +28%
Today : $68.86 — upside +9%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : May 26, 27
UBS ↗
May 22, 26
■ Neutral neutral · not a buy · 🎯$61
Price at call : $57.21 — gap to target +7%
Today : $68.86 — gap to target -11%
🎯 on CNC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : May 22, 27
▲ Buy · 🎯$72
Price at call : $57.77 — upside +25%
Today : $68.86 — upside +5%
🎯 on CNC : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : May 21, 27
Mizuho ↗
May 20, 26
■ Neutral neutral · not a buy · 🎯$58
Price at call : $58.28 — gap to target -0%
Today : $68.86 — gap to target -16%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : May 20, 27
Deutsche Bank ↗
May 20, 26
▲ Buy · 🎯$80
Price at call : $58.28 — upside +37%
Today : $68.86 — upside +16%
🎯 on CNC : no call matured yet · 📊 on Health : 53.1% · +4.5% (292 calls)
in progress (365j)
matures : May 20, 27
TD Cowen ↗
May 4, 26
■ Hold neutral · not a buy · 🎯$47
Price at call : $52.98 — gap to target -11%
Today : $68.86 — gap to target -32%
🎯 on CNC : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : May 4, 27
Wells Fargo ↗
May 1, 26
■ Equal-Weight neutral · not a buy · 🎯$56
Price at call : $53.56 — gap to target +5%
Today : $68.86 — gap to target -19%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : May 1, 27
UBS ↗
Apr 29, 26
■ Neutral neutral · not a buy · 🎯$55
Price at call : $53.69 — gap to target +2%
Today : $68.86 — gap to target -20%
🎯 on CNC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 29, 27
Oppenheimer ↗
Apr 29, 26
▲ Outperform · 🎯$58
Price at call : $53.69 — upside +8%
Today : $68.86 — upside -16%
🎯 on CNC : no call matured yet · 📊 on Health : 43.5% · -0.2% (223 calls)
in progress (365j)
matures : Apr 29, 27
▲ Overweight · 🎯$60
Price at call : $53.69 — upside +12%
Today : $68.86 — upside -13%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Apr 29, 27
Barclays ↗
Apr 29, 26
▲ Overweight · 🎯$63
Price at call : $53.69 — upside +17%
Today : $68.86 — upside -9%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 29, 27
▲ Buy · 🎯$58
Price at call : $53.98 — upside +7%
Today : $68.86 — upside -16%
🎯 on CNC : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Apr 29, 27
▲ Buy · 🎯$60
Price at call : $53.98 — upside +11%
Today : $68.86 — upside -13%
🎯 on CNC : no call matured yet · 📊 on Health : 48.1% · +2.0% (362 calls)
in progress (365j)
matures : Apr 29, 27
Jefferies ↗
Apr 20, 26
■ Hold neutral · not a buy · 🎯$39
Price at call : $39.14 — gap to target -0%
Today : $68.86 — gap to target -43%
🎯 on CNC : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Apr 20, 27
JP Morgan ↗
Mar 19, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $34.4 — gap to target +19%
Today : $68.86 — gap to target -40%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Mar 19, 27
Mizuho ↗
Mar 11, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $35.86 — gap to target +14%
Today : $68.86 — gap to target -40%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Mar 11, 27
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $43.27 — gap to target +4%
Today : $68.86 — gap to target -35%
🎯 on CNC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Mar 4, 27
Wells Fargo ↗
Feb 18, 26
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $43.07 — gap to target +2%
Today : $68.86 — gap to target -36%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Feb 18, 27
■ Neutral neutral · not a buy · 🎯$41
Price at call : $38.04 — gap to target +8%
Today : $68.86 — gap to target -40%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Feb 9, 27
Wells Fargo ↗
Jan 7, 26
■ Equal-Weight neutral · not a buy · 🎯$43
Price at call : $46.92 — gap to target -8%
Today : $68.86 — gap to target -38%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jan 7, 27
Barclays ↗
Jan 5, 26
▲ Overweight · 🎯$54
Price at call : $44.68 — upside +21%
Today : $68.86 — upside -22%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Jan 5, 27
Bernstein ↗
Nov 21, 25
▲ Outperform · 🎯$45
Price at call : $38.17 — upside +18%
Today : $68.86 — upside -35%
🎯 on CNC : no call matured yet · 📊 on Health : 55.7% · +5.7% (70 calls)
in progress (365j)
matures : Nov 21, 26
Wells Fargo ↗
Nov 12, 25
■ Equal-Weight neutral · not a buy · 🎯$35
Price at call : $36.09 — gap to target -3%
Today : $68.86 — gap to target -49%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Nov 12, 26
JP Morgan ↗
Nov 4, 25
■ Neutral neutral · not a buy · 🎯$38
Price at call : $36.84 — gap to target +3%
Today : $68.86 — gap to target -45%
🎯 on CNC : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Nov 4, 26
Barclays ↗
Nov 4, 25
■ Equal-Weight neutral · not a buy · 🎯$44
Price at call : $36.11 — gap to target +22%
Today : $68.86 — gap to target -36%
🎯 on CNC : no call matured yet · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Nov 4, 26
TD Cowen ↗
Oct 31, 25
■ Hold neutral · not a buy · 🎯$34
Price at call : $34.5 — gap to target -1%
Today : $68.86 — gap to target -51%
🎯 on CNC : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 31, 26
Goldman Sachs ↗
Oct 31, 25
▼ Sell · 🎯$38
Price at call : $34.5 — upside +10%
Today : $68.86 — upside -45%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Oct 31, 26
UBS ↗
Oct 30, 25
■ Neutral neutral · not a buy · 🎯$42
Price at call : $35.37 — gap to target +19%
Today : $68.86 — gap to target -39%
🎯 on CNC : no call matured yet · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Oct 30, 26
■ Neutral neutral · not a buy · 🎯$41
Price at call : $35.37 — gap to target +16%
Today : $68.86 — gap to target -40%
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
in progress (365j)
matures : Oct 30, 26
▲ Buy · 🎯$45
Price at call : $35.02 — upside +28%
Today : $68.86 — upside -35%
🎯 on CNC : no call matured yet · 📊 on Health : 49.4% · +2.3% (263 calls)
in progress (365j)
matures : Oct 30, 26
Morgan Stanley ↗
Oct 14, 25
■ Equal-Weight neutral · not a buy · 🎯$38
Price at call : $35.79 — gap to target +6%
Today : $68.86 — gap to target -45%
🎯 on CNC : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 14, 26
Goldman Sachs ↗
Oct 14, 25
▼ Sell · 🎯$33
Price at call : $36.44 — upside -9%
Today : $68.86 — upside -52%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Oct 14, 26
Mizuho ↗
Oct 9, 25
■ Neutral neutral · not a buy · 🎯$40
Price at call : $37.83 — gap to target +6%
Today : $68.86 — gap to target -42%
🎯 on CNC : no call matured yet · 📊 on Health : 51.4% · +3.4% (222 calls)
in progress (365j)
matures : Oct 9, 26
Wells Fargo ↗
Oct 7, 25
■ Equal-Weight neutral · not a buy · 🎯$41
Price at call : $38.45 — gap to target +7%
Today : $68.86 — gap to target -40%
🎯 on CNC : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Oct 7, 26
▲ Overweight · 🎯$65
Price at call : $33.78 — upside +92%
Today : $68.86 — upside -6%
Expected +92% · Actual +101% · Reason (≥ +15%) : ✓ Yes
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+100.9%
stock +101% · XLV +21%
matured Jul 2, 26
▲ Overweight · 🎯$90
Price at call : $58 — upside +55%
Today : $68.86 — upside +31%
Expected +55% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-29.6%
stock -30% · XLV +9%
matured Dec 11, 25
▲ Overweight · 🎯$90
Price at call : $72.62 — upside +24%
Today : $68.86 — upside +31%
Expected +24% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-49.3%
stock -49% · XLV -6%
matured Oct 1, 25
▲ Overweight · 🎯$90
Price at call : $75.35 — upside +19%
Today : $68.86 — upside +31%
Expected +19% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-56.6%
stock -57% · XLV -12%
matured Sep 20, 25
▲ Overweight · 🎯$90
Price at call : $73.47 — upside +22%
Today : $68.86 — upside +31%
Expected +22% · Actual -54% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-53.6%
stock -54% · XLV -10%
matured Sep 10, 25
▲ Overweight · 🎯$90
Price at call : $78.16 — upside +15%
Today : $68.86 — upside +31%
Expected +15% · Actual -62% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-62.4%
stock -62% · XLV -11%
matured Aug 19, 25
▲ Overweight · 🎯$90
Price at call : $66.12 — upside +36%
Today : $68.86 — upside +31%
Expected +36% · Actual -60% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-59.5%
stock -60% · XLV -9%
matured Jul 23, 25
▲ Overweight · 🎯$90
Price at call : $68.98 — upside +30%
Today : $68.86 — upside +31%
Expected +30% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-20.0%
stock -20% · XLV -7%
matured Jun 12, 25
▲ Overweight · 🎯$90
Price at call : $72.78 — upside +24%
Today : $68.86 — upside +31%
Expected +24% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-15.7%
stock -16% · XLV -6%
matured Apr 4, 25
▲ Overweight · 🎯$90
Price at call : $74.22 — upside +21%
Today : $68.86 — upside +31%
Expected +21% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-20.3%
stock -20% · XLV +4%
matured Dec 14, 24
▲ Overweight · 🎯$82
Price at call : $74.21 — upside +10%
Today : $68.86 — upside +19%
Expected +10% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
-18.7%
stock -19% · XLV +10%
matured Nov 20, 24
▲ Overweight · 🎯$82
Price at call : $67.81 — upside +21%
Today : $68.86 — upside +19%
Expected +21% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on CNC : 17% (12 calls matureds) · 📊 on Health : 38.3% · -3.4% (345 calls)
+12.9%
stock +13% · XLV +19%
matured Sep 13, 24

Frequently asked questions

Should I buy Centene Corporation stock?

This isn't buy advice. For Centene Corporation, the analyst consensus is "Hold", with an average price target of $69.00 (+0% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Centene Corporation). We show the numbers — you decide.

Is it too late to buy Centene Corporation? How high can it go?

The most bullish analyst target on Centene Corporation is $80.00 (+16% above today's price); the average is $69.00. That's the upside they see. Check how reliable those analysts have actually been on Centene Corporation on our site before trusting it.

Is Centene Corporation still a good buy?

The most useful "opinion" isn't an opinion — it's a track record: 25 analysts have a real record on Centene Corporation, the best hitting 100% over 3 calls. Current consensus: "Hold". Make your call on data, not noise.

Should you invest in Centene Corporation? The case for and against

The arguments for and against, one by one, from the numbers: why invest in CNC (and why hesitate).

What has Centene Corporation's past performance been?

Historical returns and a "how much if I had invested" calculator: CNC performance & returns.

What is the best month to buy CNC?

The 12 months ranked by the stock's past returns: best & worst month to buy CNC.

Other Health stocks

Go further

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)